The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
Open accessAbstract
Background & aims Several case series have reported the effects of fecal microbiota transplantation (FMT) for ulcerative colitis (UC). We assessed the efficacy and safety of FMT for patients with UC in a double-blind randomized trial.Methods Patients with mild to moderately active UC (n = 50) were assigned to groups that underwent FMT with feces from healthy donors or were given autologous fecal microbiota (control); each transplant was administered via nasoduodenal tube at the start of the study and 3 weeks later. The study was performed at the Academic Medical Center in Amsterdam from June 2011 through May 2014. The composite primary end point was clinical remission (simple clinical colitis activity index scores ≤2) combined with ≥1-point decrease in the Mayo endoscopic score at week 12. Secondary end points were safety and microbiota composition by phylogenetic microarray in fecal samples.Results Thirty-seven patients completed the primary end point assessment. In the intention-to-treat analysis, 7 of 23 patients who received fecal transplants from healthy donors (30.4%) and 5 of 25 controls (20.0%) achieved the primary end point (P = .51). In the per-protocol analysis, 7 of 17 patients who received fecal transplants from healthy donors (41.2%) and 5 of 20 controls (25.0%) achieved the primary end point (P = .29). Serious adverse events occurred in 4 patients (2 in the FMT group), but these were not considered to be related to the FMT. At 12 weeks, the microbiota of responders in the FMT group was similar to that of their healthy donors; remission was associated with proportions of Clostridium clusters IV and XIVa.Conclusions In this phase 2 trial, there was no statistically significant difference in clinical and endoscopic remission between patients with UC who received fecal transplants from healthy donors and those who received their own fecal microbiota, which may be due to limited numbers. However, the microbiota of responders had distinct features from that of nonresponders, warranting further study. ClinicalTrials.gov Number: NCT01650038.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, in two randomized controlled trials of UC patients, FMT responders showed a higher similarity to their donors than nonresponders. 61,62”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [61]
In the citing paper
“One trial, in which two faecal transplants were given via the upper GI route, showed no difference in clinical or endoscopic remission between the faecal transplant group and the control group (given autologous stool).76”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [76]
In the citing paper
“Since that meta-analysis, two randomised controlled trials in UC show discrepant results.”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [76]
In the citing paper
“Remission (full Mayo score <3 and complete mucosal healing) was achieved in 24% of patients after FMT and 5% with placebo; stool from patients receiving FMT had greater microbial diversity than that of patients given placebo.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [77]
In the citing paper
“In the study by Moayyedi et. al, seventy-five patients with active UC were randomized to a weekly FMT or water enema for 6 weeks, and there was a statistically significant difference in remission, the primary outcome, between the two groups.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [77]
In the citing paper
“However, some researchers did not find significant differences in the efficacy of FMT, which may be related to the number and cycle of enemas, preparation process, and limited numbers (147, 148).”
From Stress triggers flare of inflammatory bowel disease in children and adults (2019) · cites this paper as [148]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P. J., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A. D., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,910
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Self-citationCoated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712243172603 · Cited by 3,037
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
Self-citationVedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P. J., Sands, B. E., Hanauer, S. B., Colombel, J., Sandborn, W. J., Assche, G. V., Axler, J. L., Kim, H. J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,892
Classification of Inflammatory Bowel Disease
Lennard‐Jones, J. E. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909091339 · Cited by 2,022
Canoco Reference Manual and User’s Guide: Software for Ordination (version 5.0)
ter Braak, C. J. F., & Šmilauer, P. (2012) · Cited by 1,898
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789
Claesson, M. J., O’Sullivan, Ó., Wang, Q., Nikkilä, J., Marchesi, J. R., Smidt, H., de Vos, W. M., Ross, R. P., & O’Toole, P. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006669 · Cited by 900
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 922
Levast, B., Fontaine, M., Nancey, S., Déchelotte, P., Dore, J. M., & Lehert, P. (2023) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000568 · Cited by 33
A review of engraftment assessments following fecal microbiota transplant
Herman, C., Barker, B. M., Bartelli, T. F., Chandra, V., Krajmalnik‐Brown, R., Jewell, M., Li, L., Liao, C., McAllister, F. M., Nirmalkar, K., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2525478 · Cited by 34
Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease
Wang, A. Y., Popov, J., & Pai, N. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i47.10304 · Cited by 33
Wang, L., Zhang, P., Chen, J., Li, C., Tian, Y., & Xu, F. (2022) · Food Research International · doi:10.1016/j.foodres.2022.112400 · Cited by 34
Wei, Z.-J., Dong, H.-B., Ren, Y.-T., & Jiang, B. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-3236 · Cited by 32
Scaldaferri, F., Pecere, S., Petito, V., Zambrano, D., Fiore, L., Lopetuso, L. R., Schiavoni, E., Bruno, G., Gerardi, V., Laterza, L., et al. (2016) · Transplantation Proceedings · doi:10.1016/j.transproceed.2015.12.040 · Cited by 32
Reciprocal interaction of diet and microbiome in inflammatory bowel diseases
Schaubeck, M., & Haller, D. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000216 · Cited by 33
Jeon, S. R., Chai, J., Kim, C., & Lee, C. (2018) · Current Infectious Disease Reports · doi:10.1007/s11908-018-0627-8 · Cited by 32
Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?
Zhou, Y., Xu, H., Huang, H., Li, Y., Chen, H., He, J., Du, Y., Chen, Y., Zhou, Y., & Nie, Y. (2019) · BioMed Research International · doi:10.1155/2019/3469754 · Cited by 32
The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease
Haifer, C., Leong, R. W. L., & Paramsothy, S. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.08.009 · Cited by 32
Bénard, M. V., Arretxe, I., Wortelboer, K., Harmsen, H. J. M., Davids, M., de Bruijn, C. M. A., Benninga, M. A., Hugenholtz, F., Herrema, H., & Ponsioen, C. Y. (2023) · Microorganisms · doi:10.3390/microorganisms11092238 · Cited by 32
Self-citationRicciuto, A., Sherman, P. M., & Laxer, R. M. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108415 · Cited by 33
Targeting the gut microbiota in inflammatory bowel diseases: where are we?
Benech, N., & Sokol, H. (2023) · Current Opinion in Microbiology · doi:10.1016/j.mib.2023.102319 · Cited by 31
Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease
Schulberg, J. D., & Cruz, P. P. D. (2016) · Internal Medicine Journal · doi:10.1111/imj.13003 · Cited by 32
Fecal Microbiota Transplantation and Its Potential Therapeutic Uses in Gastrointestinal Disorders
Heath, R. D. (2017) · Northern Clinics of Istanbul · doi:10.14744/nci.2017.10692 · Cited by 32
Fecal Microbiota Transplantation in Gastrointestinal and Extraintestinal Disorders
Ianiro, G., Segal, J. P., Mullish, B. H., Quraishi, M. N., Porcari, S., Fabiani, G., Gasbarrini, A., & Cammarota, G. (2020) · Future Microbiology · doi:10.2217/fmb-2020-0061 · Cited by 31
Lei, J., Xie, Y., Sheng, J., & Song, J. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2056054 · Cited by 31
Xu, B., Fu, Y., Yin, N., Qin, W., Huang, Z., Xiao, W., Huang, H., Mei, Q., Fan, J., Zeng, Y., et al. (2024) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00303.2023 · Cited by 30
Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools
Murgiano, M., Bartocci, B., Puca, P., Vincenzo, F. D., GAUDIO, A. D., Papa, A., Cammarota, G., Gasbarrini, A., Scaldaferri, F., & Lopetuso, L. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073059 · Cited by 30
Cammarota, G., Pecere, S., Ianiro, G., Masucci, L., & Currò, D. (2016) · Digestive Diseases · doi:10.1159/000443362 · Cited by 30
Brüssow, H. (2016) · Microbial Biotechnology · doi:10.1111/1751-7915.12391 · Cited by 31
Lê, A., Mantel, M., Marchix, J., Bodinier, M., Jan, G., & Rolli‐Derkinderen, M. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00002.2022 · Cited by 35
The practice of fecal microbiota transplantation in inflammatory bowel disease
Arora, U., Kedia, S., & Ahuja, V. (2023) · Intestinal Research · doi:10.5217/ir.2023.00085 · Cited by 32
New targets for the treatment of ulcerative colitis: Gut microbiota and its metabolites
Li, H., Pan, M., Li, Y., Cui, M., & Zhang, M. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.05.006 · Cited by 29
DuPont, H. L., Jiang, Z., Dupont, A. W., & Utay, N. S. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06102-y · Cited by 30
Liu, J., Lin, H., Cao, M., Tan, L., Lin, A., Xu, W., Wang, H., He, J., Li, Y., Tang, H., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1124256 · Cited by 29
Alagna, L., Palomba, E., Mangioni, D., Bozzi, G., Lombardi, A., Ungaro, R., Castelli, V., Prati, D., Vecchi, M. L., Muscatello, A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165619 · Cited by 31
Olesen, S. W., & Gerardin, Y. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa170 · Cited by 29
Zou, M., Jie, Z., Cui, B., Wang, H., Feng, Q., Zou, Y., Zhang, X., Yang, H., Wang, J., Zhang, F., et al. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12744 · Cited by 28
van Lingen, E., Nooij, S., Terveer, E. M., Crossette, E. M., Prince, A., Bhattarai, S. K., Watson, A., Galazzo, G., Menon, R., Szabady, R. L., et al. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae043 · Cited by 28
Bénard, M. V., de Goffau, M. C., Blonk, J., Hugenholtz, F., van Buuren, J., Paramsothy, S., Kaakoush, N. O., D’Haens, G., Borody, T. J., Kamm, M. A., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.10.001 · Cited by 28
Self-citationPark, S., Kang, Y., Koh, H., & Kim, S. (2020) · Korean Journal of Pediatrics · doi:10.3345/cep.2019.00500 · Cited by 28
The gut microbiota and gut disease
Fehily, S. R., Basnayake, C., Wright, E. K., & Kamm, M. A. (2021) · Internal Medicine Journal · doi:10.1111/imj.15520 · Cited by 30
How to Manipulate the Microbiota: Fecal Microbiota Transplantation
Fuentes, S., & de Vos, W. M. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-31248-4_10 · Cited by 28
Self-citationTherapeutic Modulation of Gut Microbiota in Functional Bowel Disorders
Lee, H. J., Choi, J., Ryu, H. S., Choi, C. H., Kang, E. H., Park, K. S., Min, Y. W., & Hong, K. S. (2017) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm16124 · Cited by 29
Manipulating the Microbiome With Fecal Transplantation to Treat Ulcerative Colitis
Kelly, C. R., & Ananthakrishnan, A. N. (2019) · JAMA · doi:10.1001/jama.2018.20397 · Cited by 28
Sebastian, S. A., Kaiwan, O., Co, E. L., Mehendale, M., & Mohan, B. P. (2024) · Spartan Medical Research Journal · doi:10.51894/001c.123397 · Cited by 27
Gefen, R., Dourado, J., Emile, S. H., Wignakumar, A., Rogers, P. D., Aeschbacher, P., Garoufalia, Z., Horesh, N., & Wexner, S. D. (2025) · Techniques in Coloproctology · doi:10.1007/s10151-025-03113-7 · Cited by 27
Intestinal microbiota in primary sclerosing cholangitis
Hov, J. R., & Kummen, M. (2016) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000334 · Cited by 29
The Need for Personalized Approaches to Microbiome Modulation
Jain, N. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00144 · Cited by 27
The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease
Stojek, M., Jabłońska, A., & Adrych, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184055 · Cited by 28
Tan, X.-Y., Xie, Y.-J., Liu, X., Li, X., & Jia, B. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/8266793 · Cited by 27
Fecal transplants in spondyloarthritis and uveitis: ready for a clinical trial?
Choi, R. Y., Asquith, M. J., & Rosenbaum, J. T. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000506 · Cited by 27
Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease
Ning, L., Lou, X., Zhang, F., & Xu, G. (2019) · Mediators of Inflammation · doi:10.1155/2019/2624941 · Cited by 27
Clinical Review on the Utility of Fecal Microbiota Transplantation in Immunocompromised Patients
Abu‐Sbeih, H., Ali, F. S., & Wang, Y. (2019) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0677-6 · Cited by 27
Kousgaard, S. J., Michaelsen, T. Y., Nielsen, H. L., Kirk, K. F., Brandt, J., Albertsen, M., & Thorlacius‐Ussing, O. (2020) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2020.1748221 · Cited by 27
The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection
Goldenberg, S. D., & Merrick, B. (2021) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936120981526 · Cited by 28
Inflammatory bowel disease and the gut microbiota
Wu, N., Mah, C., Koentgen, S., Zhang, L., Grimm, M., El-Omar, E. M., & Hold, G. L. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s002966512100197x · Cited by 27
Ren, R., Gao, X., Shi, Y., Li, J., Peng, L., Sun, G., Wang, Z., Yan, B., Zhi, J., & Yang, Y. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.742255 · Cited by 26
Rejuvenating the human gut microbiome
Ke, S., Weiss, S. T., & Liu, Y. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.05.005 · Cited by 26
Zaman, S., Akingboye, A. A., Mohamedahmed, A. Y., Peterknecht, E., Bhattacharya, P., El‐Asrag, M. E., Iqbal, T. H., Quraishi, M. N., & Beggs, A. D. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad120 · Cited by 26
Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges
Vetter, M., & Neurath, M. F. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17727388 · Cited by 26
The Changes in the p53 Protein across the Animal Kingdom Point to Its Involvement in Longevity
Bartas, M., Brázda, V., Volná, A., Červeň, J., Pečínka, P., & Zawacka‐Pankau, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168512 · Cited by 29
Luu, L. D. W., Pandey, A., Paramsothy, S., Ngo, C., Castaño‐Rodríguez, N., Liu, C., Kamm, M. A., Borody, T. J., Man, S. M., & Kaakoush, N. O. (2024) · Nature Communications · doi:10.1038/s41467-024-46983-5 · Cited by 25
Gut microbiota in inflammation and colorectal cancer: A potential Toolbox for Clinicians
Grellier, N., Severino, A., Archilei, S., Kim, J., Gasbarrini, A., Cammarota, G., Porcari, S., & Benech, N. (2024) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2024.101942 · Cited by 26
Fecal Microbiota Transplantation in the Treatment of Chronic Pouchitis: A Systematic Review
Cold, F., Kousgaard, S. J., Halkjær, S. I., Petersen, A. M., Nielsen, H. L., Thorlacius‐Ussing, O., & Hansen, L. H. (2020) · Microorganisms · doi:10.3390/microorganisms8091433 · Cited by 25
Mahmoudi, H., & Hossainpour, H. (2022) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_131_22 · Cited by 25
Chen, Q., Fan, Y., Zhang, B., Yan, C., Chen, Z., Wang, L., Hu, Y., Huang, Q., Su, J., Ren, J., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1086885 · Cited by 25
Gut microbiome–based therapeutics in inflammatory bowel disease
Hu, K. A., & Gubatan, J. M. B. (2023) · Clinical and Translational Discovery · doi:10.1002/ctd2.182 · Cited by 25
A Personalized Approach to Managing Inflammatory Bowel Disease.
Kingsley, M. J., & Abreu, M. T. (2016) · PubMed Central · Cited by 25
Spalinger, M. R., Schwarzfischer, M., Hering, L., Shawki, A., Sayoc, A., Santos, A. N., Gottier, C., Lang, S., Bäbler, K., Geirnaert, A., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0201-1 · Cited by 25
Exploring the Genetic Diversity of the 16S rRNA Gene of Akkermansia Muciniphila in IBD and IBS
Presti, A. L., CHIERICO, F. D., Altomare, A., Zorzi, F., Cella, E., Putignani, L., Guarino, M. P. L., Monteleone, G., Cicala, M., Angeletti, S., et al. (2019) · Future Microbiology · doi:10.2217/fmb-2019-0175 · Cited by 25
Tang, L., Feng, W., Cheng, J.-J., & Gong, Y.-N. (2020) · International Journal of Colorectal Disease · doi:10.1007/s00384-020-03599-7 · Cited by 24
Zhang, W., Jin, Z., Yang, Z., Zhang, J., Ma, X., Guan, J. Z., Sun, B., & Chen, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.818111 · Cited by 25
Repeated fecal microbiota transplantation in a child with ulcerative colitis
Shimizu, H., Arai, K., Abe, J., Nakabayashi, K., Yoshioka, T., Hosoi, K., & Kuroda, M. (2016) · Pediatrics International · doi:10.1111/ped.12967 · Cited by 24
Park, L. (2016) · Annals of Gastroenterology · doi:10.20524/aog.2016.0098 · Cited by 24
Zeitz, J., Bissig, M., Barthel, C., Biedermann, L., Scharl, S., Pohl, D., Frei, P., Vavricka, S. R., Fried, M., Rogler, G., et al. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000783 · Cited by 24
Aroniadis, O. C., Drossman, D. A., & Simrén, M. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000431 · Cited by 25
Banking feces: a new frontier for public blood banks?
Baunwall, S. M. D., Hvas, C. L., Dahlerup, J. F., Mikkelsen, S., Ehlers, L. H., Hammeken, L. H., Licht, T. R., Bahl, M. I., & Erikstrup, C. (2019) · Transfusion · doi:10.1111/trf.15422 · Cited by 24
Wu, X., Dai, M., Buch, H., Bai, J., Long, W.-W., Long, C., Tang, X., Tu, H., Zhang, R., Zhu, C., et al. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819869144 · Cited by 24
FMT for ulcerative colitis: closer to the turning point
Cammarota, G., & Ianiro, G. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0131-0 · Cited by 24
Lopetuso, L. R., Deleu, S., Puca, P., Abreu, M. T., Armuzzi, A., Barbara, G., Caprioli, F., Ng, S. C., Costello, S. P., Damiani, A., et al. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf013 · Cited by 23
Self-citationFarah, A., Paul, P., Khan, A. S., Sarkar, A., Laws, S., & Châari, A. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1435030 · Cited by 24
Han, T., Zhang, Y., Zheng, G., & Guo, Y. M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1704651 · Cited by 24
Functional relevance of microbiome signatures: The correlation era requires tools for consolidation
Buttó, L. F., & Haller, D. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.02.010 · Cited by 23
Cao, Y., Zhang, B., Wu, Y., Wang, Q., Wang, J., & Shen, F. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/5480961 · Cited by 23
Lee, J.-J., Yong, D., Suk, K. T., Kim, D. J., Woo, H., Lee, S. S., & Kim, B. S. (2021) · Microorganisms · doi:10.3390/microorganisms9020352 · Cited by 23
Hou, K., Wu, Z., Chen, Y., Zhu, D., Zheng, Y., & Ali, K. B. (2021) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892816666210929164930 · Cited by 23
Human gut homeostasis and regeneration: the role of the gut microbiota and its metabolites
Gómez, C. M. A., García-Gutiérrez, E., Escobar, J. S., & Cotter, P. D. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2142088 · Cited by 26
Liu, H., Li, J., Yuan, J., Huang, J., & Youqi, X. (2023) · BMC Microbiology · doi:10.1186/s12866-023-03107-1 · Cited by 23
Role of fecal microbiota transplantation in inflammatory bowel disease
D'Odorico, I., Bella, S. D., Monticelli, J., Giacobbe, D. R., Boldock, E., & Luzzati, R. (2018) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12603 · Cited by 23
A phytopharmacological overview of medicinal plants used for prophylactic and treatment of colitis
Akkol, E. K., Karpuz, B., Sobarzo‐Sánchez, E., & Khan, H. Z. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111628 · Cited by 23
Causal role of the gut microbiome in certain human diseases: a narrative review
Prosty, C. J., Katergi, K., Papenburg, J., Lawandi, A., Lee, T. C., Shi, H., Burnham, P., Swem, L. R., Routy, B., Yansouni, C. P., et al. (2024) · eGastroenterology · doi:10.1136/egastro-2024-100086 · Cited by 22
Kistangari, G., López, R., & Shen, B. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001057 · Cited by 22
Sonnenberg, E., & Siegmund, B. (2016) · Digestion · doi:10.1159/000452621 · Cited by 22
Pinto, S., Šajbenová, D., Benincà, E., Nooij, S., Terveer, E. M., Keller, J. J., Jong, A. E. V. D. M., Bogaards, J. A., & Steyerberg, E. W. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae137 · Cited by 21
Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Primer for Internists
Syal, G., Kashani, A., & Shih, D. Q. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.03.010 · Cited by 21
Bolte, L. A., Klaassen, M. A. Y., Collij, V., Vila, A. V., Fu, J., van der Meulen, T. A., de Haan, J. J., Versteegen, G. J., Dotinga, A., Zhernakova, A., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249405 · Cited by 21
Clinical Diagnosis and Phar-maceutical Management of Inflammatory Bowel Disease
M’Koma, A. E. (2023) · Medical Research Archives · doi:10.18103/mra.v11i1.3135 · Cited by 21
The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly
Cheng, Y., & Fischer, M. (2017) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-017-0143-1 · Cited by 21
Jackson, B. D., & Cruz, P. P. D. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1530109 · Cited by 21
Pai, N., Popov, J., Hill, L., & Hartung, E. E. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030120 · Cited by 21
Kang, G.-U., Park, S., Jung, Y., Jee, J. J., Kim, M.-S., Lee, S., Lee, D., Shin, J., & Koh, H. (2022) · Gut and Liver · doi:10.5009/gnl210369 · Cited by 20
The emerging microbiome‐based approaches to IBD therapy: From SCFAs to urolithin A
Rudiansyah, M., Jasim, S. A., Azizov, B., Samusenkov, V. O., Abdelbasset, W. K., Yasin, G., Mohammad, H. J., Jawad, M. A., Mahmudiono, T., Hosseini‐Fard, S. R., et al. (2022) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13131 · Cited by 20
Current perspectives on fecal microbiota transplantation in inflammatory bowel disease
Singh, A., Midha, V., Chauhan, N. S., & Sood, A. (2024) · Indian Journal of Gastroenterology · doi:10.1007/s12664-023-01516-8 · Cited by 20
Zhang, Y. J., Bousvaros, A., Docktor, M., Kaplan, A. L., Rufo, P. A., Leier, M., Weatherly, M., Zimmerman, L. A., Nguyen, L. T. T., Barton, B., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-68619-w · Cited by 20
Microbiome-based companion diagnostics: no longer science fiction?
Raes, J. (2016) · Gut · doi:10.1136/gutjnl-2015-311015 · Cited by 20
Tabbaa, O. M., Aboelsoud, M. M., & Mattar, M. C. (2018) · Gastroenterology Research · doi:10.14740/gr1091 · Cited by 20
Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy
Sood, A., Singh, A., Midha, V., Mahajan, R., Kao, D. H., Rubin, D. T., & Bernstein, C. N. (2020) · Crohn s & Colitis 360 · doi:10.1093/crocol/otaa067 · Cited by 21
Woloszynek, S., Pastor, S. J., Mell, J. C., Nandi, N., Sokhansanj, B. A., & ROSEN, G. L. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.01.003 · Cited by 20
Metadata
- Authors
- Rossen, N. G., Fuentes, S., van der Spek, M. J., Tijssen, J. G., Hartman, J. H. A., Duflou, A., Löwenberg, M., van den Brink, G. R., Mathus-Vliegen, E. M. H., de Vos, W. M., Zoetendal, E. G., D’Haens, G. R., & Ponsioen, C. Y.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Wageningen University & Research (NL)
- Corresponding author
- Ponsioen, Cyriel Y.
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 149
- Issue
- 1
- Pages
- 110-118.e4
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1994882377
- Cited by
- 921
- References
- 29
- Citations by year
- 2026: 30 · 2025: 45 · 2024: 64 · 2023: 69 · 2022: 86 · 2021: 93 · 2020: 128 · 2019: 113 · 2018: 84 · 2017: 87 · 2016: 83 · 2015: 36
- FWCI
- 66.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- fecal microbiota transplantation, ulcerative colitis, clinical remission, endoscopic remission, Clostridium cluster XIVa, Clostridium cluster IV, gut microbiota composition, adverse events
- MeSH terms
- Adult, Aged, Biological Therapy, Colitis, Ulcerative, Double-Blind Method, Feces, Female, Humans, Intubation, Gastrointestinal, Male, Middle Aged, Remission Induction, Treatment Outcome, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
